NTM Info & Research Creates Educational Tool for Patients with Bronchiectasis
kalhh / Pixabay

NTM Info & Research Creates Educational Tool for Patients with Bronchiectasis

According to an article in the Baker City Herald, a non-profit organization has launched a website designed to support and educate patients with bronchiectasis. NTM Info & Research advocates for patients…

Continue Reading NTM Info & Research Creates Educational Tool for Patients with Bronchiectasis
BRCA-Mutated Breast Cancer May Negatively Impact Fertility
pandoraferrari / Pixabay

BRCA-Mutated Breast Cancer May Negatively Impact Fertility

A recent release from Yale University highlights research from Dr. Kutluk Oktay, a fertility expert, on how BRCA-mutated breast cancer may affect fertility following chemotherapy treatments. His findings suggest that women…

Continue Reading BRCA-Mutated Breast Cancer May Negatively Impact Fertility

Nuevas Inversiones de Capital Apuntan a Desarrollar un Nuevo Medicamento para la Distrofia Muscular de Duchenne

Según una historia de CureDuchenne, la compañía de biotecnología Dyne Therapeutics anunció recientemente que CureDuchenne Ventures ha realizado una inversión de capital que respaldará el desarrollo de todas las nuevas…

Continue Reading Nuevas Inversiones de Capital Apuntan a Desarrollar un Nuevo Medicamento para la Distrofia Muscular de Duchenne

Hydroxychloroquine Shortage: What About Patients with Autoimmune Disorders?

According to CNBC, there is a shortage across the country of a very important medication: hydroxychloroquine. This is somewhat unsurprising. After all, the Trump administration has been vocal about the…

Continue Reading Hydroxychloroquine Shortage: What About Patients with Autoimmune Disorders?

Seneca Biopharma Preparing for its Phase 3 Trial to Test NSI-566 for Amyotrophic Lateral Sclerosis

Seneca Biopharma, Germantown, Md., issued a press release announcing its recent meeting with the FDA to discuss elements of a final design and protocol for a Phase 3 trial investigating…

Continue Reading Seneca Biopharma Preparing for its Phase 3 Trial to Test NSI-566 for Amyotrophic Lateral Sclerosis
Nasal Vaccine Prevents Neuronal Loss in Mice Models of Alzheimer’s Disease
Free-Photos / Pixabay

Nasal Vaccine Prevents Neuronal Loss in Mice Models of Alzheimer’s Disease

According to an article in The Asahi Shimbun, Japanese scientists have developed a new vaccine to mitigate neuronal degeneration caused by Alzheimer's disease. The vaccine, delivered nasally, had promising results…

Continue Reading Nasal Vaccine Prevents Neuronal Loss in Mice Models of Alzheimer’s Disease

Compañía Recauda $80 Millones para Desarrollar un Tratamiento para la Fibrosis Quística Relacionada con Mutaciones Raras

De acuerdo a una historia de Fierce Biotech, recientemente ha habido algunos avances impresionantes en el tratamiento de la fibrosis quística. El último hito fue desarrollar y aprobar el medicamento…

Continue Reading Compañía Recauda $80 Millones para Desarrollar un Tratamiento para la Fibrosis Quística Relacionada con Mutaciones Raras
An Ornithine Transcarbamylase Deficiency Treatment Has Been Approved for Clinical Trials
Pixabay

An Ornithine Transcarbamylase Deficiency Treatment Has Been Approved for Clinical Trials

Ornithine transcarbamylase (OTC) deficiency is a disorder that can cause comas, seizures, and death, making it necessary for those affected to seek treatment. Arcturus Therapeutics aims to give those with…

Continue Reading An Ornithine Transcarbamylase Deficiency Treatment Has Been Approved for Clinical Trials

He Waited Five Years to Receive a Kidney Transplant and Then the Kidney Was Given to the Wrong Patient

According to a report by ABC News, Virtua Health, one of the largest healthcare providers in New Jersey, claimed to have a forty-year history of organ transplant completions. Nonetheless, a…

Continue Reading He Waited Five Years to Receive a Kidney Transplant and Then the Kidney Was Given to the Wrong Patient
Chemicals Linked to Development of Parkinson’s Disease, Says Dutch Neurologist
source: pixabay.com

Chemicals Linked to Development of Parkinson’s Disease, Says Dutch Neurologist

  According to Parkinson's News Today, Dutch neurologist Bastiaan Bloem, MD, believes that the development of Parkinson's disease can be attributed to chemical exposure. About Parkinson's Disease Parkinson's disease is…

Continue Reading Chemicals Linked to Development of Parkinson’s Disease, Says Dutch Neurologist
Gene Therapy Could Cure Irreversible Blindness for X-Linked Retinitis Pigmentosa
source: pixabay.com

Gene Therapy Could Cure Irreversible Blindness for X-Linked Retinitis Pigmentosa

As reported in Biospace, a new gene therapy has made notable progress towards curing x-linked retinitis pigmentosa, a disease responsible for sight loss in men. Until now, the disease irreversibly…

Continue Reading Gene Therapy Could Cure Irreversible Blindness for X-Linked Retinitis Pigmentosa